TELESIS BIO INC (TBIO) Stock Balance Sheet
NASDAQ:TBIO - Nasdaq - US1920032000 - Common Stock - Currency: USD
| MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | 13.46M | |||
| Cash Equivalents | 6.40M | 1.57M | 30.42M | 82.81M | N/A | |||
| Marketable Securities | 3.82M | 17.59M | 13.16M | N/A | N/A | |||
| Receivables | 1.33M | 5.99M | 5.85M | 3.67M | 2.27M | |||
| Inventories | 1.36M | 4.03M | 2.20M | 2.37M | 601.00K | |||
| Other Current Assets | 2.25M | 1.18M | 3.46M | 4.34M | 851.00K | |||
| Total Current Assets | 15.16M | 30.35M | 55.09M | 93.18M | 17.18M | |||
| Non-Current Assets | ||||||||
| PPE Net | 30.98M | 34.52M | 8.52M | 5.74M | 3.78M | |||
| Goodwill | 3.50M | 3.50M | 14.89M | 14.33M | 3.50M | |||
| Intangibles | 750.00K | 1.37M | 1.88M | 2.40M | 2.33M | |||
| Other Non-Current Assets | 2.34M | 676.00K | 981.00K | 609.00K | 81.00K | |||
| Total Non-Current Assets | 37.57M | 40.06M | 26.27M | 23.07M | 9.68M | |||
| TOTAL ASSETS | 52.73M | 70.41M | 81.36M | 116.26M | 26.86M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 118.00K | 112.00K | 59.00K | 684.00K | 1.42M | |||
| Accrued Expenses | 5.08M | 4.36M | 7.81M | 6.01M | 2.38M | |||
| Accounts Payable | 1.54M | 3.28M | 1.29M | 2.50M | 1.19M | |||
| Other Current Liabilities | 1.28M | 430.00K | 4.33M | 540.00K | 628.00K | |||
| Total Current Liabilities | 8.01M | 8.18M | 13.50M | 9.73M | 5.63M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 5.38M | 5.42M | 19.68M | 14.09M | 3.43M | |||
| Other Non-Current Liabilities | 29.39M | 27.27M | 1.62M | 1.65M | 4.35M | |||
| Total Non-Current Liabilities | 34.77M | 32.69M | 21.30M | 15.74M | 7.78M | |||
| TOTAL LIABILITIES | 42.78M | 40.87M | 34.80M | 25.47M | 13.41M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -182.69M | -161.47M | -113.74M | -65.27M | -26.31M | |||
| Additional Paid In Capital | 162.16M | 161.70M | 160.30M | 156.05M | 851.00K | |||
| Common Shares | 30.48M | 29.30M | 5.00K | 5.00K | 38.92M | |||
| Other Shareholders' Equity | -9.00K | 0.00 | -3.00K | N/A | N/A | |||
| Shares Outstanding | 1.77M | 1.67M | 1.65M | 1.63M | 1.62M | |||
| Tangible Book Value per Share | -13.99 | -2.77 | 18.09 | 45.46 | -19.26 | |||
| Total Shareholders' Equity | 9.95M | 29.54M | 46.56M | 90.78M | 13.46M | |||
| TOTAL LIABILITIES AND EQUITY | 52.73M | 70.41M | 81.36M | 116.26M | 26.86M | |||
| Statistics | ||||||||
| Debt/Equity | 0.54 | 0.18 | 0.42 | 0.16 | 0.26 | |||
| Current Ratio | 1.89 | 3.71 | 4.08 | 9.57 | 3.05 | |||
| Return On Assets (ROA) | -98.37% | -69.63% | -59.57% | -33.51% | -67.04% | |||
| Return On Equity (ROE) | -521.49% | -165.97% | -104.09% | -42.91% | -133.85% | |||
All data in USD , ROIC based on taxRate of 0.21